NCT05068037

Brief Summary

Perioperative stress is associated with various influences before and after surgery. Instead of benzodiazepines, patients can be calmed by non-pharmacological methods. One of these is perioperative medical hypnosis, which has also other beneficial effects such as lower opioid consumption, better wound healing, shorter hospital stays. Acupuncture is used for analgesia. Is is effective for preventing and treating nausea and vomiting. Hypothesis of the study is that perioperative acupuncture reduces the consumption of analgesics and anaesthetics during surgery. The investigators will also study the impact of acupuncture on postoperative nausea and vomiting and analgesic consumption in the postoperative recovery unit and the occurrence of postoperative delirium.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2021

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

June 3, 2021

Completed
4 months until next milestone

First Posted

Study publicly available on registry

October 5, 2021

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2022

Completed
Last Updated

November 8, 2022

Status Verified

November 1, 2022

Enrollment Period

1.3 years

First QC Date

June 3, 2021

Last Update Submit

November 6, 2022

Conditions

Keywords

MEDICAL HYPNOSISPERIOPERATIVE ACUPUNCTURE

Outcome Measures

Primary Outcomes (1)

  • Postoperative consumption of antiemetics in mg

    Postoperative nausea and vomiting will be measured in mg of antiemetics in PACU

    24 hours

Secondary Outcomes (2)

  • Postoperative consumption of analgesics in mg

    24 hours

  • Degree of satisfaction

    24 hours

Study Arms (3)

STANDARD

ACTIVE COMPARATOR

TCI anaesthesia with remifentanil (4-6 µg / ml) and propofol (4-6 µg / ml) Patients will receive an antiemetic (ondansetron 4 mg). The depth of anesthesia will be adjusted to maintain BIS values of 40-55. The remifentanil infusion will be adjusted according to the pain monitor values. Analgesia: piritramide 0.1 mg / kg and metamizole 2.5 g. PACU: Analgesia in VAS\> 3: piritramide 3 mg p.p. Antiemetic for POSB: metoclopramide 10 mg

Other: ANTIEMETICS

CONTROL

ACTIVE COMPARATOR

TCI anaesthesia with remifentanil (4-6 µg / ml) and propofol (4-6 µg / ml) Group does not receive neither acupuncture nor antiemetics. The depth of anesthesia will be adjusted to maintain BIS values of 40-55. The remifentanil infusion will be adjusted according to the pain monitor values. Analgesia: piritramide 0.1 mg / kg and metamizole 2.5 g. PACU: Analgesia in VAS\> 3: piritramide 3 mg p.p. Antiemetic for POSB: ondansetron 4 mg.

Other: NOTHING

STUDY

ACTIVE COMPARATOR

Before surgery, one of the team members will talk to the patient and perform brief medical hypnosis to gain the patient's confidence in the method and teach him the method of relaxing and building an imaginary safe place where he feels comfortable and safe. Therapeutic communication through hypnosis will be used as an additional method in order to improve the well-being and comfort of the patient, reduce stress and use sedatives. TCI anaesthesia with remifentanil (4-6 µg / ml) and propofol (4-6 µg / ml) Patients will receive acupuncture (PC6 and LI4 bilaterally) and no antiemetic The depth of anesthesia will be adjusted to maintain BIS values of 40-55. The remifentanil infusion will be adjusted according to the pain monitor values. Analgesia: piritramide 0.1 mg / kg and metamizole 2.5 g. Removal of acupuncture needles at the end of operation PACU: Analgesia in VAS\> 3: piritramide 3 mg p.p. Antiemetic for POSB: ondansetron 4 mg

Other: ACUPUNCTURE

Interventions

standard acupuncture TCM (analgesia, vomiting)

STUDY

NO ACUPUNCTURE, WITH ANTIEMETICS

STANDARD
NOTHINGOTHER

NO ACUPUNCTURE, NO ANTIEMETICS

CONTROL

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient consent

You may not qualify if:

  • Psychosis
  • No consent for the study
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Medical Centre Ljubljana

Ljubljana, 1000, Slovenia

Location

MeSH Terms

Conditions

Postoperative Nausea and VomitingPain, Postoperative

Interventions

Acupuncture TherapyAntiemetics

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsNauseaSigns and Symptoms, DigestiveSigns and SymptomsVomitingPainNeurologic Manifestations

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeuticsAutonomic AgentsPeripheral Nervous System AgentsPhysiological Effects of DrugsPharmacologic ActionsChemical Actions and UsesCentral Nervous System AgentsTherapeutic UsesGastrointestinal Agents

Study Officials

  • JASMINA MARKOVIC BOZIC, MD, PhD

    UMC LJUBLJANA

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
The participant and the outcomes assessor will not know which intervention was used
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Participants will be randomised to three arms regarding the type of intervention
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator; assist. prof., MD, PhD

Study Record Dates

First Submitted

June 3, 2021

First Posted

October 5, 2021

Study Start

May 1, 2021

Primary Completion

August 31, 2022

Study Completion

August 31, 2022

Last Updated

November 8, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations